These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2096185)

  • 1. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    J Psychoactive Drugs; 1990; 22(4):407-17. PubMed ID: 2096185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers].
    Magnavita N; Bergamaschi A; Chiarotti M; Colombi A; Deidda B; De Lorenzo G; Goggiamani A; Magnavita G; Ricciardi W; Sacco A; Spagnolo AG; Bevilacqua L; Brunati MM; Campanile T; Cappai M; Cicerone M; Ciprani F; Di Giannantonio M; Di Martino G; Fenudi L; Garbarino S; Lopez A; Mammi F; Orsini D; Ranalletta D; Simonazzi S; Stanzani C
    Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying and responding to drug abuse in the workplace: an overview.
    Seymour RB; Smith DE
    J Psychoactive Drugs; 1990; 22(4):383-405. PubMed ID: 2096184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random drug tests at work: the probability of identifying frequent and infrequent users of illicit drugs.
    DuPont RL; Griffin DW; Siskin BR; Shiraki S; Katze E
    J Addict Dis; 1995; 14(3):1-17. PubMed ID: 8555274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug screening in the workplace--scientific and legal issues.
    Sharon F; Wilkinson WE
    Nurse Pract; 1988 Feb; 13(2):41, 44-5, 48-9. PubMed ID: 3278253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral fluid testing: new technology enables drug testing without embarrassment.
    Cone EJ
    J Calif Dent Assoc; 2006 Apr; 34(4):311-5. PubMed ID: 16900989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal issues in oral fluid testing.
    Kadehjian L
    Forensic Sci Int; 2005 Jun; 150(2-3):151-60. PubMed ID: 15944055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug and alcohol testing in the workplace: moral, ethical and legal issues.
    Raskin C
    Bull Narc; 1993; 45(2):45-81. PubMed ID: 7920542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal issues facing physicians: substance abuse in the workplace.
    Clark HW; Johnson B
    Occup Med; 2002; 17(1):119-35, v. PubMed ID: 11726341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview on drug and alcohol testing in the workplace.
    Hanson M
    Bull Narc; 1993; 45(2):3-44. PubMed ID: 7920541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse in the workplace: epidemiology, effects, and industry response.
    Bush DM; Autry JH
    Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of drug abuse among workers: strengths and pitfalls of the recent Italian Workplace Drug Testing (WDT) legislation.
    Kazanga I; Tameni S; Piccinotti A; Floris I; Zanchetti G; Polettini A
    Forensic Sci Int; 2012 Feb; 215(1-3):46-50. PubMed ID: 21482052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we have the training? The ethics of workplace drug testing and the GP.
    Evans A; Thornett A
    Aust Fam Physician; 2003 Aug; 32(8):645-7. PubMed ID: 12973876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minnesota workplace drug testing. Analysis of policy and procedures.
    Reynolds JL; McGovern PM; Kochevar L; Olson DK; Hibbs BF
    AAOHN J; 1991 Nov; 39(11):523-33. PubMed ID: 1930387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New technology and new initiatives in U.S. workplace testing.
    Walsh JM
    Forensic Sci Int; 2008 Jan; 174(2-3):120-4. PubMed ID: 17434275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.